The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea
Condition(s):Maturity-Onset Diabetes of the Young, Type 3Last Updated:June 27, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Maturity-Onset Diabetes of the Young, Type 3Last Updated:June 27, 2019Completed
Condition(s):Maturity-Onset Diabetes of the Young, Type 3; Type 2 DiabetesLast Updated:July 27, 2023Completed
Condition(s):MODY1; MODY3Last Updated:August 17, 2022Completed
Condition(s):Maturity-Onset Diabetes of the Young, Type 3; Maturity Onset Diabetes of the Young, Type 1; Childhood Diabetes Mellitus; Insulin-dependent Diabetes MellitusLast Updated:January 27, 2020Unknown status
Condition(s):Maturity-onset Diabetes of the YoungLast Updated:September 5, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.